Dr. Stephanie McCarty Conner, MD

Dr. Conner practices at Columbia University Irving Medical Center in New York, New York.

Dr. Conner's NPI, 1316383698, was assigned on May 14, 2013. Dr. Conner graduated from New York Medical College in 2013. Dr. Conner holds New York license 330961-01.

Dr. Conner's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Conner's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Conner is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Conner to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conner practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Conner's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Conner is licensed in New York.

Dmand AI lists acute diabetes, congestive heart failure, gastrointestinal obstruction and sepsis among the conditions Dr. Conner treats.

CMS data shows 199 Medicare services from Dr. Conner across 6 procedure codes in 2024, for 82 Medicare patients. Medicare paid $15,891 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Conner in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Conner's median patient age at 68, with 47% women.

In 2024, Dr. Conner wrote 30 Medicare Part D claims for 16 patients. 80% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $128 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Conner for performance year 2024, reported through an alternative payment model (APM). Dr. Conner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Conner, published from 2021 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Internship and Residency, Clinical Competence and Point-of-Care Systems. Dr. Conner's most frequent co-authors are Peter Nathan Barish, MD, Stephanie Rennke, MD and Hannah Linn Archibald, MD.

CMS Open Payments shows 8 general payments to Dr. Conner from 3 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 77% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $4,796. It also lists 1 research payment totaling $2,175 in 2022.

Dr. Conner graduated from New York Medical College in 2013.

Dr. Conner is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.